James Edward Doyle - 13 Aug 2025 Form 4 Insider Report for EXACT SCIENCES CORP (EXAS)

Role
Director
Signature
/s/ James Edward Doyle by Mark Busch, attorney-in- fact
Issuer symbol
EXAS
Transactions as of
13 Aug 2025
Net transactions value
-$62,400
Form type
4
Filing time
14 Aug 2025, 16:30:16 UTC
Previous filing
16 Jun 2025
Next filing
10 Oct 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Doyle James Edward Director EXACT SCIENCES CORP., 5505 ENDEAVOR LANE, MADISON /s/ James Edward Doyle by Mark Busch, attorney-in- fact 14 Aug 2025 0001614265

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EXAS Common Stock Sale $62,400 -1,485 -2.4% $42.02 59,962 13 Aug 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sale reported in this field was effected pursuant to a Rule 10b5-1 trading plan entered into on March 9, 2025.

Remarks:

Exhibit 24 - Power of Attorney